Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
Trial details
- Registry ID
- NCT04980482
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as pegylated interferon alpha 2a
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B InfectionNCT04980482 | Arbutus Biopharma Corporation | Phase 2 | Completed | 2025-03-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |